PerpEquities

Equity · Healthcare

Merck & Co., Inc. (MRK) perpetual futures

MRK perpetual futures on 13 crypto exchanges – live perp price vs the stock, funding rate, open interest and where to trade MRKUSDT.

Merck & Co., Inc. is a global healthcare leader operating in Pharmaceuticals and Animal Health, offering medicines, vaccines, and animal health solutions to customers including wholesalers, pharmacies, hospitals, and government agencies.

$150.65+0.5%NYSE open
Open in terminal

Price chart

Interactive TradingView chart

TradingView symbol NYSE:MRK

Loads TradingView's third-party widget (about 1 MB) on demand.

Auto: underlying reference priceOpen in TradingView

Trading data

Perpetual market activity

13/13 live markets
Venues
13
Live markets
13/13
24h volume
$3.7M
Open interest
$1.8M
Best liquidity
$3.9M
LBank
Tightest spread
+0.7 bps
Bitunix
Highest volume
$1.2M
LBank
Settlement mix
USDT · 13/13
Perp/spot vol.
0.00x
Spot volume $978.5M
OI / float
0.00%
Float $371.4B
Spot performance
1D+0.46%
5D+3.83%
1M+19.02%
6M+26.65%
YTD+44.73%
1Y+81.25%

Venue matrix

13 markets

Some venue links are sponsored. We may receive a commission, and eligible users may occasionally receive trading-fee discounts, at no additional cost to you.

Trade
LBankTradeMRK/USDTTrading$150.650.0% APR
0.000% every 8h
+15.9 bps$3.9M$1.2M-USDT50x
BingXTradeMRK-USDTTrading$150.68-5.5% APR
-0.00500% every 8h
+13.9 bps$24.1K$1.2M$1.3KUSDT-
HTXTradeMRK/USDTTrading$149.84+11.0% APR
+0.010% every 8h
+173.7 bps$25.4K$353.7K$5.6KUSDT-
OurbitTradeMRK/USDTTrading$150.600.0% APR
0.000% every 8h
+17.2 bps$53.9K$345.8K$111.8KUSDT20x
BinanceTradeMRK/USDTTrading$150.600.0% APR
0.000% every 8h
+15.9 bps$20K$227.6K$74.5KUSDT-
BybitTradeMRK/USDTTrading$150.570.0% APR
0.000% every 8h
+4.6 bps$7.4K$93.9K$91.4KUSDT25x
BitunixTradeMRK/USDTTrading$150.56-21.4% APR
-0.020% every 8h
+0.7 bps$28.4K$83.4K-USDT20x
BitgetTradeMRK/USDTTrading$150.510.0% APR
0.000% every 8h
+14.6 bps$488.4K$71.8K$47.6KUSDT20x
XT.comTradeMRK/USDTTrading$150.56+11.0% APR
+0.010% every 8h
+50.2 bps$46.3K$41K$1.3MUSDT20x
OKXTradeMRK/USDTTrading$150.560.0% APR
0.000% every 8h
+8.6 bps$2.6K$31.6K$18.5KUSDT20x
PhemexTradeMRK / USDTTrading$150.640.0% APR
0.000% every 8h
+21.2 bps$37.7K$19.4K$48.9KUSDT20x
BloFinTradeMRK/USDTTrading$150.65-3.2% APR
-0.00296% every 8h
+15.9 bps$7.9K$9.4K$46.1KUSDT20x
Gate.ioTradeMRK/USDTTrading$150.510.0% APR
0.000% every 8h
+59.0 bps$42.2K$5.7K$100.5KUSDT20x

Embed this asset

MRK perpetuals · perpequities.comMRK perpetuals · perpequities.com
<a href="https://perpequities.com/stocks/mrk-perp"><img src="https://perpequities.com/badge/mrk-perp.svg" width="240" height="64" alt="MRK perpetuals · perpequities.com" loading="lazy"></a>

Tradability

Execution quality

Broad liquidity · 10 of 13 venues absorb $10k · Typical cost: +59.6 bps – +82.6 bps

Cheapest execution: LBank · +14.5 bps

Too thin: BloFin, OKX

No fresh book data: HTX

Taker execution estimate incl. approx. fees - maker fills are not guaranteed.

Best venues for this underlying

Best liquidity

MRK

Tightest spread

MRK

Highest volume

MRK

Funding history

Stored venue snapshots by market

Company data

Company fundamentals

Updated 6h ago
Market cap
$376.3B
Updated 6h ago
Revenue
$66.4B
Trailing 12 months
Revenue growth
+3%
Next fiscal year
Profit margin
+4.8%
P/E
120.9
Peer P/E 26.6
Free cash flow
$16.1B
Trailing 12 months
More metrics
Net income
$3.2B
Trailing 12 months
P/S
5.7
Peer P/E
26.6
Similar listed perps
Revenue estimate
$67.1B
Next fiscal year
Earnings
2026-10-29
Revenue est. $17.3B · Updated 6h ago
Dividend
$0.85
2026-09-15

Fundamental detail

Annual + quarterly
Latest revenue$64.9B
Net margin+28.1%
Free cash flow$12.4B
Net debt$36B
2020$41.5B
2021$48.7B
2022$59.3B
2023$60.1B
2024$64.2B
2025$64.9B
PeriodRevenueGrowthNet incomeFCF
2020$41.5B+6%$7.1B$5.8B
2021$48.7B+17%$13B$9.7B
2022$59.3B+22%$14.5B$14.7B
2023$60.1B+1%$365M$9.1B
2024$64.2B+7%$17.1B$18.1B
2025$64.9B+1%$18.3B$12.4B
PeriodGross marginOperating marginNet marginROEROA
2020+67.2%+13.4%+17.0%+27.9%+7.7%
2021+72.0%+27.1%+26.8%+34.2%+12.3%
2022+70.6%+30.8%+24.5%+31.6%+13.3%
2023+73.2%+4.9%+0.6%+1.0%+0.3%
2024+76.3%+31.5%+26.7%+37.0%+14.6%
2025+72.0%+36.2%+28.1%+34.7%+13.3%
PeriodCashDebtNet debtCurrent ratio
2020$8.1B$33.4B$25.4B1.02
2021$8.1B$34.6B$26.5B1.27
2022$12.7B$32B$19.3B1.47
2023$6.8B$36.3B$29.4B1.25
2024$13.2B$38.3B$25B1.36
2025$14.6B$50.5B$36B1.54
PeriodMarket capEnterprise valueP/SP/E
2020$197.3B$222.7B4.828.0
2021$193.9B$220.4B4.014.9
2022$280.9B$300.2B4.719.4
2023$277.7B$307.1B4.6778.7
2024$251.9B$276.9B3.914.7
2025$263.4B$299.3B4.114.4
Q3 2024$16.7B
Q4 2024$15.6B
Q1 2025$15.6B
Q2 2025$15.8B
Q3 2025$17.2B
Q4 2025$16.3B
Q1 2026$16.3B
Q2 2026$16.6B
PeriodRevenueGrowthNet incomeFCF
Q3 2024$16.7B+4%$3.2B$8.5B
Q4 2024$15.6B+7%$3.7B$2.5B
Q1 2025$15.6B-1%$5.1B$1.2B
Q2 2025$15.8B-2%$4.4B$2.5B
Q3 2025$17.2B+3%$5.8B$6.8B
Q4 2025$16.3B+4%$3B$1.8B
Q1 2026$16.3B+4%-$4.2B$2.9B
Q2 2026$16.6B+5%-$1.3B$4.5B
PeriodGross marginOperating marginNet marginROEROA
Q3 2024+75.5%+23.9%+19.0%+7.1%+2.7%
Q4 2024+75.5%+27.8%+24.0%+8.1%+3.2%
Q1 2025+75.1%+43.0%+32.5%+10.5%+4.4%
Q2 2025+75.7%+40.2%+28.0%+9.0%+3.8%
Q3 2025+75.6%+43.4%+33.7%+11.2%+4.5%
Q4 2025+70.5%+37.7%+18.2%+5.6%+2.2%
Q1 2026+81.9%-11.6%-26.0%-9.2%-3.3%
Q2 2026+73.5%-4.1%-8.0%-3.2%-1.0%
PeriodCashDebtNet debtCurrent ratio
Q3 2024$14.6B$38.1B$23.5B1.36
Q4 2024$13.2B$38.3B$25B1.36
Q1 2025$8.6B$34.8B$26.2B1.41
Q2 2025$8B$35.4B$27.4B1.42
Q3 2025$18.2B$41.4B$23.2B1.66
Q4 2025$14.6B$50.5B$36B1.54
Q1 2026$5.3B$49.1B$43.8B1.30
Q2 2026$6.8B$53.9B$47.1B1.32
PeriodMarket capEnterprise valueP/SP/E
Q3 2024$288.6B$312.1B17.322.7
Q4 2024$252.8B$277.8B16.216.8
Q1 2025$226.5B$252.7B14.511.2
Q2 2025$198.7B$226.1B12.611.2
Q3 2025$209.4B$232.6B12.29.0
Q4 2025$260.5B$296.4B16.021.9
Q1 2026$297.4B$341.1B18.3-17.5
Q2 2026$317.7B$364.7B19.1-59.5
Historical value series
Revenue
Q3 2023: $16BQ4 2023: $14.6BQ1 2024: $15.8BQ2 2024: $16.1BQ3 2024: $16.7BQ4 2024: $15.6BQ1 2025: $15.6BQ2 2025: $15.8BQ3 2025: $17.2BQ4 2025: $16.3BQ1 2026: $16.3BQ2 2026: $16.6BQ3 2023Q2 2026
Net income
Q3 2023: $4.7BQ4 2023: -$1.2BQ1 2024: $4.8BQ2 2024: $5.5BQ3 2024: $3.2BQ4 2024: $3.7BQ1 2025: $5.1BQ2 2025: $4.4BQ3 2025: $5.8BQ4 2025: $3BQ1 2026: -$4.2BQ2 2026: -$1.3BQ3 2023Q2 2026
EBITDA
Q3 2023: $7BQ4 2023: -$772MQ1 2024: $7BQ2 2024: $7.4BQ3 2024: $5.6BQ4 2024: $5.7BQ1 2025: $7.3BQ2 2025: $6.4BQ3 2025: $8.1BQ4 2025: $6.3BQ1 2026: -$2BQ2 2026: $1.4BQ3 2023Q2 2026
Free cash flow
Q3 2023: $6.8BQ4 2023: -$743MQ1 2024: $2.2BQ2 2024: $4.8BQ3 2024: $8.5BQ4 2024: $2.5BQ1 2025: $1.2BQ2 2025: $2.5BQ3 2025: $6.8BQ4 2025: $1.8BQ1 2026: $2.9BQ2 2026: $4.5BQ3 2023Q2 2026
EPS
Q3 2023: $1.86Q4 2023: -$0.48Q1 2024: $1.87Q2 2024: $2.14Q3 2024: $1.24Q4 2024: $1.48Q1 2025: $2.01Q2 2025: $1.76Q3 2025: $2.32Q4 2025: $1.19Q1 2026: -$1.72Q2 2026: -$0.54Q3 2023Q2 2026
Cash / Debt
Q3 2023 · Cash: $8.6BQ3 2023 · Debt: $34.9BQ4 2023 · Cash: $6.8BQ4 2023 · Debt: $36.3BQ1 2024 · Cash: $5.6BQ1 2024 · Debt: $34.2BQ2 2024 · Cash: $11.3BQ2 2024 · Debt: $37.8BQ3 2024 · Cash: $14.6BQ3 2024 · Debt: $38.1BQ4 2024 · Cash: $13.2BQ4 2024 · Debt: $38.3BQ1 2025 · Cash: $8.6BQ1 2025 · Debt: $34.8BQ2 2025 · Cash: $8BQ2 2025 · Debt: $35.4BQ3 2025 · Cash: $18.2BQ3 2025 · Debt: $41.4BQ4 2025 · Cash: $14.6BQ4 2025 · Debt: $50.5BQ1 2026 · Cash: $5.3BQ1 2026 · Debt: $49.1BQ2 2026 · Cash: $6.8BQ2 2026 · Debt: $53.9BQ3 2023Q2 2026
CashDebt
Profitability
Q3 2023 · Gross margin: +73.3%Q4 2023 · Gross margin: +73.3%Q1 2024 · Gross margin: +77.6%Q2 2024 · Gross margin: +76.8%Q3 2024 · Gross margin: +75.5%Q4 2024 · Gross margin: +75.5%Q1 2025 · Gross margin: +75.1%Q2 2025 · Gross margin: +75.7%Q3 2025 · Gross margin: +75.6%Q4 2025 · Gross margin: +70.5%Q1 2026 · Gross margin: +81.9%Q2 2026 · Gross margin: +73.5%Q3 2023 · Operating margin: +36.8%Q4 2023 · Operating margin: -11.7%Q1 2024 · Operating margin: +36.5%Q2 2024 · Operating margin: +38.0%Q3 2024 · Operating margin: +23.9%Q4 2024 · Operating margin: +27.8%Q1 2025 · Operating margin: +43.0%Q2 2025 · Operating margin: +40.2%Q3 2025 · Operating margin: +43.4%Q4 2025 · Operating margin: +37.7%Q1 2026 · Operating margin: -11.6%Q2 2026 · Operating margin: -4.1%Q3 2023 · Net margin: +29.7%Q4 2023 · Net margin: -8.4%Q1 2024 · Net margin: +30.2%Q2 2024 · Net margin: +33.9%Q3 2024 · Net margin: +19.0%Q4 2024 · Net margin: +24.0%Q1 2025 · Net margin: +32.5%Q2 2025 · Net margin: +28.0%Q3 2025 · Net margin: +33.7%Q4 2025 · Net margin: +18.2%Q1 2026 · Net margin: -26.0%Q2 2026 · Net margin: -8.0%Q3 2023Q2 2026
Gross marginOperating marginNet margin
Revenue growth
Q2 2024: +7.2%Q3 2024: +4.4%Q4 2024: +6.8%Q1 2025: -1.0%Q2 2025: -1.9%Q3 2025: +3.2%Q4 2025: +4.5%Q1 2026: +4.3%Q2 2026: +5.1%Q3 2023Q2 2026
Shares outstanding
Q3 2023: 2.5BQ4 2023: 2.6BQ1 2024: 2.5BQ2 2024: 2.5BQ3 2024: 2.5BQ4 2024: 2.5BQ1 2025: 2.5BQ2 2025: 2.5BQ3 2025: 2.5BQ4 2025: 2.5BQ1 2026: 2.5BQ2 2026: 2.5BQ3 2023Q2 2026
Valuation
Q3 2023 · P/E: 13.8Q4 2023 · P/E: -56.8Q1 2024 · P/E: 17.4Q2 2024 · P/E: 14.9Q3 2024 · P/E: 22.7Q4 2024 · P/E: 16.8Q1 2025 · P/E: 11.2Q2 2025 · P/E: 11.2Q3 2025 · P/E: 9.0Q4 2025 · P/E: 21.9Q1 2026 · P/E: -17.5Q2 2026 · P/E: -59.5Q3 2023 · P/S: 16.4Q4 2023 · P/S: 19.0Q1 2024 · P/S: 21.0Q2 2024 · P/S: 20.1Q3 2024 · P/S: 17.3Q4 2024 · P/S: 16.2Q1 2025 · P/S: 14.5Q2 2025 · P/S: 12.6Q3 2025 · P/S: 12.2Q4 2025 · P/S: 16.0Q1 2026 · P/S: 18.3Q2 2026 · P/S: 19.1Q3 2023Q2 2026
P/EP/S
Revenue
2018: $42.3B2019: $39.1B2020: $41.5B2021: $48.7B2022: $59.3B2023: $60.1B2024: $64.2B2025: $64.9B20182025
Net income
2018: $6.2B2019: $9.8B2020: $7.1B2021: $13B2022: $14.5B2023: $365M2024: $17.1B2025: $18.3B20182025
EBITDA
2018: $14B2019: $11.4B2020: $10.2B2021: $17.9B2022: $21.3B2023: $6.9B2024: $25.7B2025: $28.3B20182025
Free cash flow
2018: $8.3B2019: $10B2020: $5.8B2021: $9.7B2022: $14.7B2023: $9.1B2024: $18.1B2025: $12.4B20182025
EPS
2018: $2.322019: $3.822020: $2.782021: $5.142022: $5.712023: $0.142024: $6.742025: $7.2820182025
Cash / Debt
2018 · Cash: $8B2018 · Debt: $25.1B2019 · Cash: $9.7B2019 · Debt: $27.4B2020 · Cash: $8.1B2020 · Debt: $33.4B2021 · Cash: $8.1B2021 · Debt: $34.6B2022 · Cash: $12.7B2022 · Debt: $32B2023 · Cash: $6.8B2023 · Debt: $36.3B2024 · Cash: $13.2B2024 · Debt: $38.3B2025 · Cash: $14.6B2025 · Debt: $50.5B20182025
CashDebt
Profitability
2018 · Gross margin: +68.1%2019 · Gross margin: +69.3%2020 · Gross margin: +67.2%2021 · Gross margin: +72.0%2022 · Gross margin: +70.6%2023 · Gross margin: +73.2%2024 · Gross margin: +76.3%2025 · Gross margin: +72.0%2018 · Operating margin: +21.1%2019 · Operating margin: +20.3%2020 · Operating margin: +13.4%2021 · Operating margin: +27.1%2022 · Operating margin: +30.8%2023 · Operating margin: +4.9%2024 · Operating margin: +31.5%2025 · Operating margin: +36.2%2018 · Net margin: +14.7%2019 · Net margin: +25.2%2020 · Net margin: +17.0%2021 · Net margin: +26.8%2022 · Net margin: +24.5%2023 · Net margin: +0.6%2024 · Net margin: +26.7%2025 · Net margin: +28.1%20182025
Gross marginOperating marginNet margin
Revenue growth
2019: -7.5%2020: +6.1%2021: +17.3%2022: +21.7%2023: +1.4%2024: +6.7%2025: +1.2%20182025
Shares outstanding
2018: 2.7B2019: 2.6B2020: 2.5B2021: 2.5B2022: 2.5B2023: 2.5B2024: 2.5B2025: 2.5B20182025
Valuation
2018 · P/E: 30.42019 · P/E: 22.62020 · P/E: 28.02021 · P/E: 14.92022 · P/E: 19.42023 · P/E: 778.72024 · P/E: 14.72025 · P/E: 14.42018 · P/S: 4.52019 · P/S: 5.72020 · P/S: 4.82021 · P/S: 4.02022 · P/S: 4.72023 · P/S: 4.62024 · P/S: 3.92025 · P/S: 4.120182025
P/EP/S

Refreshed 6h ago

Next catalyst

Catalysts

Earnings
2026-10-29
Revenue est. $17.3B · Updated 6h ago
Dividend
$0.85
2026-09-15

No unusual perp activity right now.

Research data

Analysts, filings and peer context

Estimates

6
DateEPS estimateRevenue estimateGrowthAnalysts
FY 20262.75$67.1B+3%14
FY 20279.54$70.2B+8%14
FY 202810.53$74.3B+14%8
FY 202910.18$74.3B+15%5
FY 203010.03$75.2B+16%5
Q1 20272.21$16.5B+1%8

Company events

6
2026-10-29EarningsActual - / Estimate 2.22-
2026-09-15Dividend$0.85-
2026-08-04EarningsActual -0.13 / Estimate -0.27Beat
2026-06-15Dividend$0.85-
2026-04-30EarningsActual -1.28 / Estimate -1.47Beat
2026-03-16Dividend$0.85-

Peer comparison

Similar listed perps

FMP company data

Company intelligence

Updated: Sep 4, 2026, 09:39 AM UTC

Company profile

Sector
Healthcare
Industry
Drug Manufacturers - General
Chief executive
Robert Davis
Employees
74,000
IPO date
Jan 13, 1978
Country
US
Exchange
New York Stock Exchange
Website
Altman Z-scorei4.02
Piotroski scorei5/9
FMP ratingiB-
Owner earningsi$4.79B$1.94 per share
ESG risk ratingiB+Industry rank: 2 out of 27

Rating factors

Return on equityi
4
Return on assetsi
4
Debt to equityi
1
Price to earningsi
1
Price to booki
1
Market cap history
2026-06-032026-09-03Latest: $372.93BHigh: $372.93BLow: $283.54B
Largest fund holders
FundWeightShares held
VTI0.45%78.6M
VOO0.5%64.8M
SCHD4.83%36.1M
IVV0.55%32.9M
1657.T0.42%32.9M
XAW.TO0.32%32.9M
XUU.TO0.49%32.9M
SPY0.55%30.3M
FXAIX0.49%30.1M
VTV1.19%23.5M
VGHAX6.05%18.3M
XLV5.93%17.6M

Frequently asked questions

Where can I trade MRK perpetual futures?

Merck & Co., Inc. (MRK) perpetual futures trade on 13 crypto venues, including LBank, BingX, HTX. PerpEquities compares them by live price, funding rate, open interest and liquidity.

Can I trade MRK around the clock?

Yes. Unlike the underlying stock, MRK perpetuals trade 24/7 — including weekends and outside regular market hours.

What is the funding rate on MRK perpetuals?

Right now the MRK perp funding rate is 0.0% annualized (venue median), ranging from -21.4% to +11.0% across 13 venues. A positive rate means longs pay shorts. PerpEquities shows the live rate and its history for every venue.

How does the MRK perp price compare to the Merck & Co., Inc. stock?

The venue-median MRK perp mark is $150.6 versus a reference stock price of $150.7, a basis of -0.1%. Perps follow the stock through an index price; the gap widens when funding or liquidity diverge between venues.

What is a MRK perpetual future?

A MRK perpetual is a derivative that tracks the price of Merck & Co., Inc. with no expiry date. It lets you take long or short exposure to Merck & Co., Inc. on crypto venues, around the clock.

What is MRKUSDT perpetual?

MRKUSDT is the symbol most crypto exchanges use for the Merck & Co., Inc. perpetual settled in USDT (Tether). It tracks the MRK share price through an index, trades 24/7 with leverage and never expires.